Chemotherapy is a reasonable option for adjuvant therapy in the treatment of high-intermediate risk endometrial cancer
Year: 2014
Type: article
Source: Gynecologic Oncology
Institution: University of Alabama at Birmingham
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2057067017
